CONNEX-3: A Study to Test Whether Iclepertin Improves Learning and Memory in People With Schizophrenia
Clinical trial NCT04860830 · COMPLETED
Trial details
- NCT number
- NCT04860830
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-09
- Primary completion
- 2024-10-28
- Enrollment
- 609
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.